Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Public ClinicalTrials.gov record NCT05089734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label, Global, Multicenter, Randomized, Phase 3 Study of Sacituzumab Govitecan Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical study is to compare the study drug, sacituzumab govitecan-hziy (SG), versus docetaxel in participants with advanced or metastatic (cancer that has spread) non-small cell lung cancer (NSCLC).
Study identification
- NCT ID
- NCT05089734
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 603 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2021 (Actual)
- Primary completion
- Nov 29, 2023 (Actual)
- Completion
- Jan 2027 (Estimated)
- Last update posted
- May 7, 2026
2021 – 2027
United States locations
- U.S. sites
- 37
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Oncology and Hematology, LLC. | Anchorage | Alaska | 99508 | — |
| USOR - Arizona Oncology Associates Tucson - Wilmot | Tucson | Arizona | 85711 | — |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | — |
| Rocky Mountain Cancer Centers - Aurora | Aurora | Colorado | 80012 | — |
| Florida Cancer Specialists (Administration and Drug Shipment) | Fort Myers | Florida | 33901 | — |
| Woodlands Medical Specialists, PA | Pensacola | Florida | 32503 | — |
| Florida Cancer Specialists | St. Petersburg | Florida | 33705 | — |
| Florida Cancer Specialists | West Palm Beach | Florida | 33401 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60607 | — |
| Illinois Cancer Specialists | Niles | Illinois | 60714 | — |
| Siouxland Regional Cancer Center dba June E. Nylen Cancer Center | Sioux City | Iowa | 51101 | — |
| Kansas City VA Medical Center | Westwood | Kansas | 66205 | — |
| Baptist Health Lexington | Lexington | Kentucky | 40503 | — |
| Maryland Oncology Hematology, P.A. | Clinton | Maryland | 20735 | — |
| Lahey Hospital & Medical Center | Burlington | Massachusetts | 01805 | — |
| Park Nicollet Frauenshuh Cancer Center | Saint Paul | Minnesota | 55101 | — |
| Nebraska Hematology - Oncology | Lincoln | Nebraska | 68506 | — |
| Comprehensive Cancer Centers of Nevada | Henderson | Nevada | 89052 | — |
| Broome Oncology, LLC | Johnson City | New York | 13790 | — |
| Stony Brook Cancer Center | Stony Brook | New York | 11794 | — |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | — |
| FirstHealth Outpatient Cancer Center | Pinehurst | North Carolina | 28374 | — |
| W.G (Bill) Hefner VAMC | Salisbury | North Carolina | 28144 | — |
| Zangmeister Cancer Center | Columbus | Ohio | 43219 | — |
| Tennessee Oncology, PLLC | Chattanooga | Tennessee | 37404 | — |
| Baptist Clinical Research Institute | Memphis | Tennessee | 38120 | — |
| Texas Oncology - Bedford | Bedford | Texas | 76022 | — |
| Texas Oncology - Denison | Denison | Texas | 75020 | — |
| Texas Oncology - Denton South | Denton | Texas | 76201 | — |
| Texas Oncology Cancer Care and Research Center | McAllen | Texas | 78503 | — |
| USOR - Texas Oncology - McKinney | McKinney | Texas | 75071 | — |
| Texas Oncology - Paris | Paris | Texas | 75460 | — |
| Texas Oncology-Plano East | Plano | Texas | 75075 | — |
| Texas Oncology-Plano West | Plano | Texas | 75093 | — |
| Shenandoah Oncology Associates, PC | Winchester | Virginia | 22601 | — |
| University of Wisconsin Clinical Science Center | Madison | Wisconsin | 53792 | — |
| Froedtert Hospital/Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 190 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05089734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05089734 live on ClinicalTrials.gov.